-
1
-
-
0442313538
-
Physiopathology of acne vulgaris: Recent data, new understanding of the treatments
-
Pawin H, Beylot C, Chivot M, et al. Physiopathology of acne vulgaris: recent data, new understanding of the treatments. Eur J Dermatol. 2004:14(1):4-12.
-
(2004)
Eur J Dermatol
, vol.14
, Issue.1
, pp. 4-12
-
-
Pawin, H.1
Beylot, C.2
Chivot, M.3
-
2
-
-
0642337440
-
Pathogenesis of acne: Recent research advances
-
Harper JC, Thiboutot DM. Pathogenesis of acne: Recent research advances. Adv Dermatol. 2003;19:1-10.
-
(2003)
Adv Dermatol
, vol.19
, pp. 1-10
-
-
Harper, J.C.1
Thiboutot, D.M.2
-
3
-
-
0038729440
-
Management of acne: A report from a Global Alliance to Improve Outcomes in Acne
-
and Global Alliance to Improve Outcomes in Acne.
-
Gollnick H, Cunliffe W, Berson D, et al; and Global Alliance to Improve Outcomes in Acne. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(1 Suppl):1S-37S.
-
(2003)
J Am Acad Dermatol
, vol.49
, Issue.1 SUPPL.
-
-
Gollnick, H.1
Cunliffe, W.2
Berson, D.3
-
4
-
-
33947185823
-
Guidelines of care for acne vulgaris management
-
American Academy of Dermatology/American Academy of Dermatology Association
-
Strauss JS, Krowchuk DP, Leyden JJ, et al; American Academy of Dermatology/American Academy of Dermatology Association. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651-663.
-
(2007)
J Am Acad Dermatol
, vol.56
, Issue.4
, pp. 651-663
-
-
Strauss, J.S.1
Krowchuk, D.P.2
Leyden, J.J.3
-
5
-
-
0042328102
-
A review of the use of combination therapies for the treatment of acne vulgaris
-
Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol. 2003;49(3 Suppl):S200-S210.
-
(2003)
J Am Acad Dermatol
, vol.49
, Issue.3 SUPPL.
-
-
Leyden, J.J.1
-
6
-
-
0021358999
-
Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity
-
Kazmierowski JA, Ross JE, Peizner DS, Wuepper KD. Dermatitis herpetiformis: Effects of sulfones and sulfonamides on neutrophil myeloperoxidase-mediated iodination and cytotoxicity. J Clin Immunol. 1984;4(1):55-64.
-
(1984)
J Clin Immunol
, vol.4
, Issue.1
, pp. 55-64
-
-
Kazmierowski, J.A.1
Ross, J.E.2
Peizner, D.S.3
Wuepper, K.D.4
-
7
-
-
0024165477
-
Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels
-
Maloff BL, Fox D, Bruin E, Di Meo TM. Dapsone inhibits LTB4 binding and bioresponse at the cellular and physiologic levels. Eur J Pharmacol. 1988;158(1-2):85-89.
-
(1988)
Eur J Pharmacol
, vol.158
, Issue.1-2
, pp. 85-89
-
-
Maloff, B.L.1
Fox, D.2
Bruin, E.3
Di Meo, T.M.4
-
8
-
-
0031442335
-
Anti-inflammatory action of dapsone: Inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction
-
Debol SM, Herron MJ, Nelson RD. Anti-inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattractant-induced signal transduction. J Leukoc Biol. 1997;62(6):827-836.
-
(1997)
J Leukoc Biol
, vol.62
, Issue.6
, pp. 827-836
-
-
Debol, S.M.1
Herron, M.J.2
Nelson, R.D.3
-
9
-
-
0001035601
-
The treatment of acne vulgaris with dapsone
-
Ross CM. The treatment of acne vulgaris with dapsone. Br J Dermatol. 1961;73:367 370.
-
(1961)
Br J Dermatol
, vol.73
, Issue.367
, pp. 370
-
-
Ross, C.M.1
-
11
-
-
0019772864
-
Experience with Disulone in the treatment of severe nodular acne
-
in French
-
Geniaux M, Meraud JP, Texier L. Experience with Disulone in the treatment of severe nodular acne [in French]. LARC Med. 1981;1:67.
-
(1981)
LARC Med
, vol.1
, pp. 67
-
-
Geniaux, M.1
Meraud, J.P.2
Texier, L.3
-
12
-
-
0034861699
-
Dapsone and sulfones in dermatology: Overview and update
-
Zhu YI, Stiller MJ. Dapsone and sulfones in dermatology: Overview and update. J Am Acad Dermatol. 2001;45(3):420-434.
-
(2001)
J Am Acad Dermatol
, vol.45
, Issue.3
, pp. 420-434
-
-
Zhu, Y.I.1
Stiller, M.J.2
-
13
-
-
34547621610
-
Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris
-
Thiboutot DM, Willmer J, Sharata H, et al. Pharmacokinetics of dapsone gel, 5% for the treatment of acne vulgaris. Clin Pharmacokinet. 2007;46(8):697-712.
-
(2007)
Clin Pharmacokinet
, vol.46
, Issue.8
, pp. 697-712
-
-
Thiboutot, D.M.1
Willmer, J.2
Sharata, H.3
-
14
-
-
33847020777
-
Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris
-
for United States/Canada Dapsone Gel Study Group
-
Draelos ZD, Carter E, Maloney JM, et al. for United States/Canada Dapsone Gel Study Group. Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol. 2007;56(3):439.e1-439.e10.
-
(2007)
J Am Acad Dermatol
, vol.56
, Issue.3
-
-
Draelos, Z.D.1
Carter, E.2
Maloney, J.M.3
-
15
-
-
33847064403
-
Five percent dapsone topical gel: Safety and efficacy with long-term (one year) treatment for acne vulgaris
-
Roberts J, Maloney M, Ling M, Lucky AW. Five percent dapsone topical gel: Safety and efficacy with long-term (one year) treatment for acne vulgaris. J Am Acad Dermatol. 2005;52:5.
-
(2005)
J Am Acad Dermatol
, vol.52
, pp. 5
-
-
Roberts, J.1
Maloney, M.2
Ling, M.3
Lucky, A.W.4
-
16
-
-
20444441044
-
Cumulative irritation potential of adapalene 0.1% cream and gel compared to tazarotene cream 0.05% and 0.1%
-
Dosik JS, Homer K, Arsonnaud S. Cumulative irritation potential of adapalene 0.1% cream and gel compared to tazarotene cream 0.05% and 0.1%. Cutis. 2005;75(5):289-293.
-
(2005)
Cutis
, vol.75
, Issue.5
, pp. 289-293
-
-
Dosik, J.S.1
Homer, K.2
Arsonnaud, S.3
-
17
-
-
80053016786
-
-
package insert. Fort Worth (TX): Galderma Laboratories, L.P.
-
Differin® Gel, 0.1% [package insert]. Fort Worth (TX): Galderma Laboratories, L.P.; 2003.
-
(2003)
Differin® Gel, 0.1%
-
-
|